Expansion footprint FST has grown beyond Plano to multiple Texas locations (Plano/Frisco, Dallas, Rockwall, Southlake, Lubbock) with an IVF lab centralized in Plano, indicating ongoing geographic expansion and potential cross-location demand for services and centralized lab capabilities.

Advanced ART Recent technology launch of time-lapse incubator and CHLOE Viewer (Mar 27, 2025) signals a commitment to cutting-edge ART tools, creating opportunities to upsell premium lab services, patient experience enhancements, and partnerships around innovative fertility technologies.

Strong outcomes High US pregnancy and birth rates with over 1,600 babies born since 2005, plus consistently recognized as a leading infertility center, positioning FST as a preferred partner for employer wellness programs, referral networks, and high-value patient acquisition collaborations.

Financial health Estimated revenue in the $10–25M range with a sizable staff (51–200), suggesting stable operations and capacity for technology investments, client services scaling, and potential financing partnerships or patient financing program expansion.

Third-party ready In-house egg donor program, donor egg/sperm options, and gestational carrier evaluation indicate readiness for partnerships with donor networks, insurance alternates, and fertility travel or concierge services to attract a broader patient segment.